Clinical Trials Directory

Trials / Conditions / ROS1 Gene Rearrangement

ROS1 Gene Rearrangement

7 registered clinical trials studyying ROS1 Gene Rearrangement — 3 currently recruiting.

StatusTrialSponsorPhase
RecruitingREPotrectinib in ROS1-positive Non-small Cell Lung Cancer Patients With Active Brain mEtastasis
NCT06315010
MedSIRPhase 2
Not Yet RecruitingReal-world Observational Study of Targeted Therapy in Patients With Advanced ROS1-positive NSCLC
NCT06694129
National Cancer Center, China—
UnknownPembrolizumab, Lenvatinib and Chemotherapy After TKIs in NSCLC
NCT04989322
Dr Joanne CHIUPhase 2
TerminatedBrigatinib and Binimetinib in Treating Patients With Stage IIIB-IV ALK or ROS1-Rearranged Non-small Cell Lung
NCT04005144
University of California, San FranciscoPhase 1
RecruitingStudy of Crizotinib for ROS1 and MET Activated Lung Cancer
NCT04084717
University Health Network, TorontoPhase 2
UnknownX-396 Capsule in Advanced NSCLC Patients With ROS1 Gene Rearrangement
NCT03608007
Betta Pharmaceuticals Co., Ltd.Phase 2
Active Not RecruitingCeritinib and Everolimus in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Stage IIIB-I
NCT02321501
M.D. Anderson Cancer CenterPhase 1